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Pre-eclampsia is defined as the development of hypertension
with proteinuria in the second half of pregnancy in a
previously normotensive woman. It is a disorder peculiar to
human pregnancy and is one of the leading causes of maternal
and perinatal death in the Transkei region of South Africa.
Although extensively investigated, the pathogenesis of pre-
eclampsia is still unclear.1-6 Studies from Pakistan,7 China,8
Scandinavia9 and the USA10 have suggested that pre-eclampsia
behaves like essential hypertension, where there is glucose
intolerance associated with insulin resistance.11-13 But other
studies in the Western world and in Africa have shown normal
glucose tolerance and absence of insulin resistance in pre-
eclampsia.14-20 This study investigated the glucose tolerance
status of pre-eclamptic women in rural Transkei, an area with a
high prevalence of the condition.
Methods and materials
Subjects
Subjects were selected from pregnant women with mild to
moderate pre-eclampsia admitted to the antenatal ward of
Umtata General Hospital, the regional hospital for the Transkei
region. Selection was on the basis of blood pressure (BP) ≥
140/90 mmHg and proteinuria ≥ 1+ (using the urinary dipstick
method) at 25 or more weeks’ gestation. The following
categories of patients were excluded from the study: those with
severe pre-eclampsia or impending eclampsia; those with
chronic hypertension, i.e. hypertension before pregnancy; those
with diabetes mellitus; and those on any medication known to
affect carbohydrate or fat metabolism.
Subjects for the control group were selected from pregnant
women attending routine antenatal clinics at Umtata General
Hospital and the surrounding primary health care centres.
Criteria for selection were pregnancy with normal BP (< 120/
80 mmHg), no proteinuria, no diabetes mellitus, and not on
any medication known to affect carbohydrate or fat
metabolism. 
Informed consent was obtained from subjects before
recruitment into the study. The subjects were counselled and
were free to withdraw from the study at any time if they so
wished. The study was approved by the Research Ethics
Committee of the University of Transkei (now Walter Sisulu
University). 
Anthropometric measurements
Single measurements of height were done, to the nearest
centimetre (e.g. 0.4 was rounded off to 0, whereas 0.5 was
rounded off to 1), with subjects wearing underclothes only,
barefooted, feet together, back and heels firmly against the
upright of the height scale. Weight was measured on a balance
scale to the nearest kilogram. The subjects were weighed in
their underclothes with no shoes on.
Blood pressure measurement
BP measurements were performed by a single observer
throughout the study.  Measurements were taken after a 30-
minute rest period, and were done on the mid-arm, with the
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Objective. To determine the relationship between pre-eclampsia
and glucose intolerance among rural women from the Transkei
region of South Africa. 
Methods. Women with confirmed pre-eclampsia underwent a 
75 g, 3-hour oral glucose tolerance test. A control group of
normotensive pregnant women were subjected to a similar
glucose tolerance test. Pre-eclampsia was defined as blood
pressure (BP) of at least 140/90 mmHg occurring for the first
time after mid-pregnancy, in association with proteinuria. The
control group comprised women with singleton pregnancy and
normal BP, with age, parity and gestational age comparable to
those of the pre-eclampsia group.
Results. There were 117 subjects in the pre-eclampsia group and
94 in the normotensive pregnancy group. Mean fasting plasma
glucose levels in the pre-eclampsia group (3.88 ± 0.05 mmol/l)
were similar to levels in the normotensive group (3.97± 0.05
mmol/l, p = 0.214). Peak post-load plasma glucose levels in the
pre-eclampsia group (5.96 ± 0.12 mmol/l) were similar to levels
in the normotensive group (5.71 ± 0.13 mmol/l, p = 0.180), and
post-load incremental glucose area under the curve in the pre-
eclampsia group (4.16 ± 0.21) was similar to that in the
normotensive group (3.95 ± 0.21, p = 0.495). 
Conclusion. Rural women with pre-eclampsia from the Transkei
region of South Africa have normal glucose tolerance.
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subject seated upright. A mercury sphygmomanometer was
used and the Korotkoff phase IV was taken as the diastolic
point. BP measurements were performed before the oral
glucose tolerance test (OGTT), 24 hours after delivery, and 6
weeks after delivery.
Proteinuria
Random urine samples were analysed for protein using both
the urinary dipstick method and laboratory analysis. A dipstick
reading of 1+ or more was indicative of proteinuria. A
laboratory reading of urinary protein 100 mg/l or more was
confirmatory of proteinuria.
Oral glucose tolerance test 
All the glucose tolerance tests were performed in the antenatal
wards of Umtata General Hospital. All subjects received a
standard diet (8 694 kJ/day) the day before the glucose
tolerance test. The test was performed at 07h00 after an
overnight (10-hour) fast.  The subject remained seated
throughout the test. 
Each subject was given glucose solution (75 g glucose/300 ml
water) orally. Venous blood samples were obtained at the
following times: 0, 60, 120 and 180 minutes after the ingestion
of glucose. Blood samples were drawn into vaccutainer tubes
containing potassium oxalate and immediately centrifuged at 
3 000 rpm for 5 minutes. The plasma was transported to the
laboratory on dry ice and was stored at –70oC until the time of
batch analysis. The plasma glucose was measured using the
colorimetric, hexokinase glucose-6-phosphate dehydrogenase
method using the Beckman glucose reagent kit (Beckman
Synchron CX system, Brea, Calif., USA). 
Glucose tolerance was evaluated by means of the fasting
plasma glucose level, the peak plasma glucose level following
ingestion of a 75 g glucose load, and the incremental glucose
area under the curve (GAUC), calculated using the trapezoid
formula, following ingestion of a 75 g glucose load.
Statistical analysis
Data were expressed as means ± standard deviation (SD). All
the anthropometric, biochemical and BP measurements had
normal distribution patterns.  Intergroup comparison was done
using the Mann-Whitney test. All data were processed and
analysed using a commercially available statistics software
package (STATISTICA).
Results
Anthropometric measurements
One hundred and seventeen subjects with pre-eclampsia and
94 subjects with normal pregnancy were recruited into the
study. Table I shows the characteristics of the pre-eclampsia
and the normal pregnancy study groups. The study groups
were similar in age, parity and gestational age. The pre-
eclampsia group had a significantly higher body weight and
body mass index (BMI).
There were subtle differences in the lipid profile between the
pre-eclampsia and normal pregnancy groups. The fasting
serum total free fatty acid concentration in the pre-eclampsia
group (0.44 ± 0.02 mmol/l) was similar to that in the normal
pregnancy group (0.40 ± 0.03 mmol/l, p = 0.7). The fasting
serum triglyceride concentration in the pre-eclampsia group
(2.32 ± 0.12 mmol/l) was significantly higher than that in the
normal pregnancy group (1.86 ± 0.07 mmol/l, p = 0.042). The
fasting serum high-density lipoprotein concentration in the pre-
eclampsia group (0.92 ± 0.03 mmol/l) was significantly lower
than that in the normal pregnancy group (1.10 ± 0.04 mmol/l, 
p = 0.037), and the fasting serum low-density lipoprotein
concentration in the pre-eclampsia group (3.03 ± 0.13 mmol/l)
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Table I. Anthropometric and biochemical profiles of the study groups 
Pre-eclampsia Normal pregnancy
Parameter N (%) Mean SD N (%) Mean SD
Age (years) 117 26.9 8.5 94 25.7 5.9
< 20 27 (23) 15 (16)
20 - 29 46 (39) 55 (59)
30+ 44 (38) 24 (25)
Parity 117 2.8 2.4 94 2.5 1.8
Primigravida 56 (48) 38 (40)
Gravida 2 - 5 42 (36) 48 (51)
Gravida 6+ 19 (16) 8 (9)
Gestational age (weeks) 117 33.0 3.5 94 33.6 3.9
Weight (kg) 117 74 18.2 94 69 11.8
Height (m) 117 1.57 0.09 94 1.58 0.08
BMI (kg/m2) 117 30.9 7.6 94 28.3 4.8
< 27.3 kg/m2 (lean) 37 (32) 47 (50)
27.3 - 32.3 kg/m2 (overweight) 47 (40) 26 (28)
≥ 32.3 kg/m2 (obese) 33 (28) 20 (22)
BMI = body mass index.
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was similar to that in the normal pregnancy group (3.06 ± 0.15
mmol/l, p = 0.85).
The results of the OGTT are given in Table II and in Fig. 1.
The fasting plasma glucose level was similar in both study
groups. There was no significant correlation between fasting
plasma glucose level and age, parity, or BMI in both study
groups.
The OGTT was normal in both study groups. There was no
significant difference in the plasma glucose levels at 60, 90 and
180 minutes of the OGTT. The post-loading peak plasma
glucose level was similar in both groups. In the pre-eclampsia
group, but not in the normal pregnancy group, there was a
significant correlation between age and peak plasma glucose
level (r = 0.33, p < 0.01). This correlation was independent of
the BMI. 
The incremental GAUC, depicted in Fig. 1, was similar in the
two groups. In both groups, the GAUC was significantly
higher in the fourth decade than in the second decade. In the
normal pregnancy group there was a significant positive
correlation between GAUC and BMI (r = 0.21, p < 0.05). This
relationship was not evident in the pre-eclampsia group.
Discussion
The present study demonstrated that glucose tolerance was
normal in our pre-eclampsia subjects despite the presence of
dyslipidaemia. Fasting blood sugar level, the post-load peak
glucose level, and the post-load incremental GAUC are
markers of insulin sensitivity. All these parameters were shown
to be normal in this study, reflecting the relative normalcy of
insulin sensitivity in our subjects. Insulin resistance is therefore
unlikely to be the main explanation for the relative
dyslipidaemia observed in our pre-eclampsia subjects.
The normal glucose tolerance observed in this study is in
conformity with findings of other recent studies14-17 which have
shown that pre-eclampsia per se is not associated with
abnormal glucose tolerance. Abnormal glucose tolerance is
observed in the gestational hypertension variant of pregnancy-
induced hypertension. In the past, there was lack of uniformity
in classifying hypertensive disorders of pregnancy. Often pre-
eclampsia and gestational hypertension have been lumped
together as different manifestations of the same disease, and
studies carried out on the basis of such classification indicated
the presence of glucose intolerance in pre-eclampsia.21,22 But
studies that clearly define and separate pre-eclampsia from
gestational hypertension demonstrate the difference in glucose
tolerance between these variants of pregnancy-induced
hypertension, probably pointing to distinctive
pathophysiology.15
Conclusion
There is normal glucose tolerance in pre-eclamptic rural black
women from the Transkei region of South Africa.
Funding for the study was received from the Medical Research
Council of South Africa.
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25th Conference on Priorities in Perinatal Care
in Southern Africa
Champagne Sports Resort, KZN 7 - 10 March 2006
The 25th Conference on Priorities in Perinatal Care will be held at Champagne Sports Resort
from 7 to 10 March 2006. This a conference that focuses primarily on trying to improve
obstetric, midwifery and neonatal care in poorly resourced areas of Southern Africa where
populations are dependent on government health services. The emphasis is on the presentation
and discussion of original research by public health practitioners, obstetricians, generalists,
midwives and neonatologists.
Invited speakers: In the spirit of the 25th anniversary of the conference, and in recognition of
the considerable contributions of South Africans to the conference, the Priorities in Perinatal
Care Association is proud to announce, the following invited guest speakers: Prof Peter Cooper,
Prof James McIntyre, Prof Eddie Mhlanga, Ms Dolly Nyasulu, Prof Bob Pattinson, Prof Alan Rothberg and
Prof Dave Woods.
Registration packs are available from the organisers: Roz or Cathy at tel: (012) 373-0825/373-1002, 
e-mail: matinfru@up.ac.za or the Priorities website: www.perinatalpriorities.co.za
Deadline dates: Abstract submission 13 January 2006
Registration and accommodation booking 17 February 2006
Early and late registration fees apply, kindly contact the organisers for more information.
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